Literature DB >> 4713690

Mumps class-specific immunoglobulins in radioimmunoassay and conventional serology.

H Daugharty, D T Warfield, W D Hemingway, H L Casey.   

Abstract

Antibodies against mumps virus have been studied by using immunoglobulin class-specific indicators labeled with (125)I in the radioimmunoassay (RIA) procedure. The immunoglobulins in paired acute and convalescent sera were allowed to react with mumps virus in a solid-phase RIA system. Class-specific immunoglobulin indicators (anti-immunoglobulin M [IgM] and anti-immunoglobulin G [IgG]) labeled with (125)I revealed that immunoglobulins of early antisera were preponderantly IgM, whereas immunoglobulins of late antisera were predominantly IgG. These indicators detected antibodies of the early (IgM) and late (IgG) phases of the immune response. These findings are consistent with the classical temporal order of appearance of 19s (IgM) and 7s (IgG) globulins. Specificity of these indicators for reacting with fractionated 7s and 19s globulins is also presented. Mumps virus RIA obtained with anti-IgG correlated well with conventional serological data obtained by neutralization and hemagglutination inhibition, but most strongly with complement-fixation data. In addition, antibody bound by solid phase was capable of distinguishing between related antigens of the myxovirus group.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4713690      PMCID: PMC422688          DOI: 10.1128/iai.7.3.380-385.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Mumps virus.

Authors:  K CANTELL
Journal:  Adv Virus Res       Date:  1961       Impact factor: 9.937

2.  The serum proteins in multiple myelomatosis.

Authors:  R A Kekwick
Journal:  Biochem J       Date:  1940-09       Impact factor: 3.857

3.  Measurement of antibody against human IgG by the neutralization of IgG-sensitized herpes simplex virus.

Authors:  C A Daniels; S E Mergenhagen; A L Notkins
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

4.  Immunoglobulin classes of neutralizing antibody formed after human inoculation with soluble adenoviral antigens.

Authors:  J R Lehrich; J A Kasel; R D Rossen
Journal:  J Immunol       Date:  1966-11       Impact factor: 5.422

5.  Anticomplementary activity of gamma G-immunoglobulins and of their subunits.

Authors:  M Waldesbuhl; R Allan; A Meylan; H Isliker
Journal:  Immunochemistry       Date:  1970-02

6.  Immunoglobulin class of influenza antibodies investigated by radioimmunoassay (RIA).

Authors:  H Daugharty; M L Davis; H S Kaye
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

7.  Solid-phase radioimmunoassay of total and influenza-specific immunoglobulin G.

Authors:  H Daugharty; D T Warfield; M L Davis
Journal:  Appl Microbiol       Date:  1972-02

8.  Distribution of antibodies within 19 S and 7 S immunoglobulins following infection with Mycoplasma pneumoniae.

Authors:  G Biberfeld
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

9.  THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. II. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN ANTIGEN DOSE REQUIREMENT FOR SUSTAINED SYNTHESIS, ANAMNESIS, AND SENSITIVITY TO X-IRRADIATION.

Authors:  S E SVEHAG; B MANDEL
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

10.  THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. I. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN KINETICS AND ANTIGEN DOSE REQUIREMENT FOR INDUCTION.

Authors:  S E SVEHAG; B MANDEL
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

View more
  14 in total

1.  Solid-phase radioimmunoassay of rubella virus immunoglobulin G and immunoglobulin M antibodies.

Authors:  K O Kalimo; O H Meurman; P E Halonen; B R Ziola; M K Viljanen; K Granfors; P Toivanen
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

2.  Screening for mumps immunity with the microtiter solid-phase radioimmunoassay.

Authors:  R Hernandez; M Just; A Bürgin-Wolff
Journal:  Infection       Date:  1976       Impact factor: 3.553

3.  Sensitive solid-phase radioimmunoassay for detection of human immunoglobulin G antibodies to varicella-zoster virus.

Authors:  M G Friedman; S Leventon-Kriss; I Sarov
Journal:  J Clin Microbiol       Date:  1979-01       Impact factor: 5.948

4.  In vitro secondary generation of cytotoxic T lymphocytes in mice with mumps virus and their mumps-specific cytotoxicity among paramyxoviruses.

Authors:  Y Hosaka; Y Yasuda; O Seriburi; M G Moran; K Fukai
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

5.  Sensitive neutralization test for virus antibody. 1. Mumps antibody.

Authors:  H Sato; P Albrecht; J T Hicks; B C Meyer; F A Ennis
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

6.  Sensitive hemagglutination inhibition test for mumps antibody.

Authors:  P Albrecht; M Klutch
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

7.  Comparison of nonspecific reactivity in indirect and reverse immunoassays for measles and mumps immunoglobulin M antibodies.

Authors:  H Tuokko
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

8.  Chemiluminescence-linked immunoassay for detection of mumps virus antibodies.

Authors:  E Konishi; S Iwasa; K Kondo; M Hori
Journal:  J Clin Microbiol       Date:  1980-08       Impact factor: 5.948

9.  Enzyme-linked immunosorbent assay (ELISA) for detection of specific IgA antibodies to mumps virus.

Authors:  B Halevy; I Sarov
Journal:  J Clin Pathol       Date:  1982-10       Impact factor: 3.411

10.  Solid-phase radioimmunoassay for antibodies to flavivirus structural and nonstructural proteins.

Authors:  D W Trent; C L Harvey; A Qureshi; D LeStourgeon
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.